Our News
August 19, 2022 – Melbourne, FL –– The Preeclampsia Foundation and the Preeclampsia Foundation Canada have announced that John Snelgrove, MD, MSc, and Samantha Wilson, PhD, are their 2022 Vision Grant research award recipients respe...
I met some amazing people while on the Re-Connect Tour 2022 this summer and came away with new friendships, renewed energy, and lasting memories. Early into the two-month tour I began thinking a lot about dads. After numerous opportunities to spend...
Stress caused by a traumatic pregnancy and delivery can often override the ability to emotionally cope, leading to psychiatric complications such as post-traumatic stress disorder (PTSD) and postpartum mood disorders (PPMD) like depression (PPD) and...
2021 Recipients Multi-omics for precision medicine in preeclampsia Principal Investigator: Kathryn J. Gray, MD, PhD Harvard Medical School and Massachusetts General Hospital (The General Hospital Corp) Center for Genomic Medicine Description: A la...
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant program is to drive research that will eliminate...
1657043233.png)
The pandemic hasn’t stopped everything. In some cases, it has been the catalyst for the kind of innovation that is poised to stay with us long past mandatory quarantines and telehealth visits. Spending two months on the road has given me in-de...
Promising New Test May Help to Rule-Out Suspected Preeclampsia in At-Risk Pregnant Women To diagnose preeclampsia, healthcare providers rely on measurable signs: a woman’s blood pressure, the amount of protein in her urine, and tests for how...
Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis Delivery of the baby and the placenta is still the only definitive management for preeclampsia, and planned delivery is recommended for all wome...
Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy Experiencing a hypertensive disorder of pregnancy increases risk for cardiovascular disease in later life. However, few studies hav...
Treatment for Mild Chronic Hypertension during Pregnancy (Results from the CHAPS Trial) Treating mild chronic hypertension with medications during pregnancy is beneficial and safe for mother and baby, according to the results of a study published...
MELBOURNE, Fla. – Preeclampsia is a life-threatening hypertensive disorder affecting 300,000 pregnant women in the U.S. annually, often yielding serious complications for mother and baby as well as long-term effects. Eleni Z. Tsigas is devoti...
April 30, 2022 - Melbourne, FL – Preeclampsia, a hypertensive disorder of pregnancy, is a leading cause of premature birth and a major contributor to adverse maternal outcomes and maternal death. This May, the Preeclampsia Foundation, a US-ba...
Related Articles
PUBLIC POLICY PRIORITIES The Preeclampsia Foundation's advocacy priorities are focused on supporting efforts to reduce maternal and infant illness and death due to preeclampsia, HELLP syndrome, a...
We did it! Act2SaveMoms has become a law December 22, 2018: This is a great day for preeclampsia and the beginning of the end of needless deaths. Late last night, President Trump...
Want to impact how your state and our nation handles maternity care?
RECOGNITION & RESPONSE IS CRITICAL Less than half of well-educated women know the signs and symptoms of preeclampsia. And still others may not share their symptoms with their healthcare pro...
INNOVATION FOR HYPERTENSIVE DISORDERS OF PREGNANCY STARTS WITH PRENATAL AND POSTPARTUM CARE Prenatal and postpartum care – as it’s generally practiced in the United States – hasn&rs...;